List of SBIR/STTR awards granted to TherapyX
TherapyXName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to TherapyX in May, 2020 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AI104067-04A1 | Phase II | 1,000,000 | May 1, 2020 | |||||||
A SBIR Phase II contract was awarded to TherapyX in July, 2020 for $807,210.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AI115877-04 | Phase II | 807,210 | July 15, 2020 | |||||||
A SBIR Phase I contract was awarded to TherapyX in July, 2018 for $320,159.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AT009800-01 | Phase I | 320,159 | July 1, 2018 | |||||||
A SBIR Phase I contract was awarded to TherapyX in August, 2019 for $239,162.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI147718-01 | Phase I | 239,162 | August 1, 2019 | |||||||
A SBIR Phase II contract was awarded to TherapyX in March, 2020 for $858,320.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44DK117687-02 | Phase II | 858,320 | March 1, 2020 | |||||||
A SBIR Phase I contract was awarded to TherapyX in March, 2019 for $388,880.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44DK117687-01A1 | Phase I | 388,880 | March 7, 2019 | |||||||
A SBIR Phase I contract was awarded to TherapyX in February, 2022 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI170069-01 | Phase I | 300,000 | February 22, 2022 | |||||||
A SBIR Phase II contract was awarded to TherapyX in February, 2017 for $1,793,879.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI115877-02 | Phase II | 1,793,879 | February 14, 2017 | |||||||
A SBIR Phase I contract was awarded to TherapyX in September, 2016 for $295,831.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK106938-01A1 | Phase I | 295,831 | September 5, 2016 | |||||||
A SBIR Phase II contract was awarded to TherapyX in June, 2017 for $2,999,994.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI080009-05A1 | Phase II | 2,999,994 | June 20, 2017 | |||||||
A SBIR Phase II contract was awarded to TherapyX in June, 2014 for $1,498,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI104067-02 | Phase II | 1,498,000 | June 15, 2014 | |||||||
A SBIR Phase I contract was awarded to TherapyX in January, 2015 for $271,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI115877-01 | Phase I | 271,000 | January 1, 2015 | |||||||
A SBIR Phase I contract was awarded to TherapyX from the U.S. Department of Health & Human Services. | SBIR | 2R44CA085097-02 | Phase I | 0 | ||||||||
A SBIR Phase I contract was awarded to TherapyX for $158,517.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA097834-01 | Phase I | 158,517 | ||||||||
A SBIR Phase I contract was awarded to TherapyX for $172,500.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI080009-01 | Phase I | 172,500 | ||||||||
A SBIR Phase I contract was awarded to TherapyX for $292,501.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI074252-01A1 | Phase I | 292,501 | ||||||||
A SBIR Phase II contract was awarded to TherapyX for $2,555,134.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA085097-02 | Phase II | 2,555,134 | ||||||||
A SBIR Phase I contract was awarded to TherapyX for $300,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI104067-01A1 | Phase I | 300,000 | ||||||||
A SBIR Phase II contract was awarded to TherapyX for $2,999,994.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI080009-02A1 | Phase II | 2,999,994 | ||||||||
A SBIR Phase I contract was awarded to TherapyX for $144,961.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK075190-01 | Phase I | 144,961 | ||||||||
A SBIR Phase II contract was awarded to TherapyX in June, 2023 for $1,201,534.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44DK117687-04 | Phase II | 1,201,534 | June 1, 2023 | |||||||
A SBIR Phase II contract was awarded to TherapyX in August, 2023 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2SB1AI104067-07 | Phase II | 1,000,000 | August 21, 2023 |
